₹165.00
Composition: Bromfenac 0.09% w/v
Packing: 5ml Sterile Ophthalmic Solution
Category: Non-Steroidal Anti-Inflammatory Drug (NSAID) for ophthalmic use
ROMPE Eye Drops contain Bromfenac 0.09% w/v, a potent NSAID ophthalmic solution indicated for the management of postoperative inflammation and ocular pain. Designed with a precision formulation, ROMPE offers superior anti-inflammatory action, faster healing, and optimal patient comfort.
Bromfenac is a second-generation NSAID that selectively inhibits the cyclooxygenase-2 (COX-2) enzyme, reducing the synthesis of prostaglandins—key mediators of inflammation. This targeted inhibition results in rapid relief from redness, pain, photophobia, and swelling of the eyes following cataract or intraocular surgery.
ROMPE is pH-balanced, well-tolerated, and designed for once or twice daily dosing, enhancing patient compliance without compromising efficacy. Its excellent ocular bioavailability ensures deep tissue penetration and sustained action, making it the preferred choice of ophthalmologists across India.
Whether used as a post-cataract prophylactic, or for non-infectious inflammatory ocular conditions, ROMPE provides consistent results with minimal side effects. Its advanced formulation allows for faster visual recovery, reduced steroid dependence, and excellent patient outcomes. Our Products
👁️ Ophthalmic Indications:
Bromfenac inhibits the COX-2 enzyme, which is upregulated after ocular trauma or surgery. By blocking prostaglandin synthesis at the source, ROMPE provides fast and focused control of inflammation without the side effects associated with corticosteroids. It also reduces intraocular pain and improves patient tolerance to light and discomfort in the postoperative phase.
“ROMPE Eye Drops, with Bromfenac 0.09%, is a trusted anti-inflammatory for post-surgical patients. I recommend it especially for cataract recovery—it reduces swelling, controls pain, and supports faster healing without the pressure concerns linked with steroids.”
ROMPE is ideal for ophthalmologists, optometrists, and hospitals as a post-op kit essential. Its combination of efficacy, tolerability, and compliance positions it as a market leader in anti-inflammatory ophthalmic therapy.
Reviews
There are no reviews yet.